GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

LabTurbo Biotech 7725.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

21.00

+0.96%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2024

Revenue

TWD 73.0m

FY2021FY2024

Net income

TWD 13.0m

FY2021FY2024

Free cash flow

−TWD 140.5m

FY2021FY2024

Shareholders' equity

TWD 1.31bn

FY2021FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021
RevenueTWD 73.0mTWD 188.1mTWD 1.34bnTWD 979.5m
Gross profitTWD 17.0mTWD 31.1mTWD 995.4mTWD 684.4m
Research and developmentTWD 84.8mTWD 82.1mTWD 66.2mTWD 31.8m
Operating income−TWD 182.5m−TWD 178.8mTWD 798.4mTWD 584.2m
Net incomeTWD 13.0m−TWD 64.3mTWD 642.8mTWD 458.5m
Diluted earnings per share0.27-1.3313.419.56

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021
Total assetsTWD 1.39bnTWD 1.40bnTWD 1.78bnTWD 1.36bn
Cash and short-term investmentsTWD 886.4mTWD 853.3mTWD 1.11bnTWD 604.7m
Total liabilitiesTWD 76.1mTWD 66.0mTWD 240.0mTWD 304.2m
DebtTWD 28.2mTWD 10.9mTWD 42.5mTWD 52.7m
Shareholders' equityTWD 1.31bnTWD 1.34bnTWD 1.54bnTWD 1.06bn
Shares outstanding48m48m48m48m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021
Cash from operations−TWD 120.6m−TWD 149.6mTWD 861.3mTWD 255.5m
Capital spending−TWD 19.9m−TWD 26.7m−TWD 60.0m−TWD 124.3m
Free cash flow−TWD 140.5m−TWD 176.3mTWD 801.4mTWD 131.2m
Dividends paid−TWD 24.2m−TWD 145.0m−TWD 145.0m−TWD 18.9m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022
RevenueTWD 36.9mTWD 31.9mTWD 41.1mTWD 22.7mTWD 165.3mTWD 332.8mTWD 1.01bn
Gross profit−TWD 22.1m−TWD 16.2mTWD 11.8m−TWD 26.3mTWD 20.9mTWD 205.0mTWD 790.4m
Operating income−TWD 93.5m−TWD 96.6m−TWD 85.4m−TWD 100.0m−TWD 81.8mTWD 98.7mTWD 699.6m
Net income−TWD 85.9m−TWD 72.4mTWD 85.4m−TWD 33.8m−TWD 30.5mTWD 99.4mTWD 543.4m
Diluted earnings per share-1.79-1.511.78-0.70-0.632.0611.24
Cash from operations−TWD 77.0m−TWD 41.0m−TWD 52.0m−TWD 32.0m−TWD 59.0m——
Capital spending—−TWD 1.0m−TWD 14.0m−TWD 9.0m−TWD 13.0m——
Free cash flow—−TWD 42.0m−TWD 66.0m−TWD 41.0m−TWD 72.0m——
Total assetsTWD 1.30bnTWD 1.39bnTWD 1.48bnTWD 1.40bnTWD 1.61bnTWD 1.78bnTWD 2.00bn
Cash and short-term investmentsTWD 806.6mTWD 886.4mTWD 916.0mTWD 853.3mTWD 977.5mTWD 1.11bnTWD 859.4m
DebtTWD 7.3mTWD 13.1mTWD 12.6mTWD 3.2mTWD 5.0mTWD 12.1mTWD 25.4m
Shareholders' equityTWD 1.21bnTWD 1.31bnTWD 1.39bnTWD 1.34bnTWD 1.37bnTWD 1.54bnTWD 1.46bn

Financial ratios

Data as of 5 Nov 2026

FY2025FY2024FY2023FY2022FY2021
Gross margin—23.3%16.5%74.2%69.9%
Operating margin—5.0%-29.3%61.3%59.2%
Net margin—17.8%-34.2%47.9%46.8%
Return on equity—1.0%-4.8%41.8%43.2%
Return on assets—0.9%-4.6%36.2%33.6%
Free cash flow yield—-9.6%-11.6%——
Revenue growth—-61.2%-86.0%37.0%—
Earnings growth—-120.1%-110.0%40.2%—
Current ratio—20.74x18.90x6.43x4.18x
Debt to equity—0.01x0.00x0.03x0.05x
Equity ratio—94.5%95.3%86.5%77.7%
Interest coverage—7.50x-325.82x1496.77x798.08x
R&D as a share of sales—116.1%43.6%4.9%3.2%
Buybacks as a share of market value0.0%0.8%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-58.0%——
Net income-69.5%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin18.4%66.9%——

Valuation history

At each fiscal year end

FY2024FY2023
Price to earnings95.0-26.3
Price to sales17.09.0

Dividends and splits

Per share, in the currency the company pays

Paid for 2 years. Last went ex-dividend on 2 Jul 2025.

FY2025FY2024
Paid in the year0.300.504

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.